Age (years) |
56.5 (±23.4) |
Sex (M/F) |
82 (70.7%)/34 (29.3%) |
BMI |
26.1 (±4) |
eGFR (mL/min) |
69.3 (±24.1) |
INR |
1.3 (±0.3) |
aPTT (s) |
41.1 (±5.9) |
Platelet count (No. ×103/μL) |
325.1 (±109) |
Coagulopathy (no/yes) |
80 (69.0%)/36 (31.0%) |
- INR > 1.5 |
32 (27.6%) |
- aPTT > 45 s |
32 (27.6%) |
- PLT < 80,000/mm3
|
10 (8.6%) |
Baseline hemoglobin (g/dL) |
7.9 (±0.9) |
Antiplatelet therapy |
23 (19.8%) |
Anticoagulant therapy |
35 (30.2%) |
Antiplatelet AND anticoagulant therapy |
0 (0%) |
Antiplatelet OR anticoagulant therapy |
58 (50.0%) |
Mechanism of pelvic trauma |
|
- Blunt |
102 (87.9%) |
- Penetrating |
14 (12.1%) |
Hemodynamic stability/instability |
72 (62.1%)/44 (37.9%) |
Young–Burgess classification of pelvic fracture |
|
- Stable |
36 (31.0%) |
- Unstable |
80 (69.0%) |
WSES classification pelvic ring injuries |
|
- Minor (grade I) |
24 (20.7%) |
- Moderate (grade II/grade III) |
48 (41.4%)–(20.7%/20.7%) |
- Severe (grade IV) |
44 (37.9%) |
Injury Severity Score |
28.8 (±15) |
Extra-pelvic injury |
78 (67.2%) |
CT angiography execution |
98 (84.5%) |
Bleeding on CT angiography |
86 (74.1%) |
- Direct sign |
56 (65.1%) |
- Indirect sign |
30 (34.9%) |
Hematoma volume (mL) |
289.1 (±309) |